These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6378082)

  • 1. [Theoretical substantiation of methods for limiting the circulation of drug-resistant staphylococci].
    Zueva VS
    Antibiotiki; 1984 Apr; 29(4):299-311. PubMed ID: 6378082
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistant coagulase negative staphylococci from clinical specimen in and around Solapur (South Maharashtra).
    Kandle S; Ghtole MP; Kamale PB; Apama T; Jahagirdar VL; Yemul VL
    J Commun Dis; 2003 Jun; 35(2):132-5. PubMed ID: 15562961
    [No Abstract]   [Full Text] [Related]  

  • 3. [Staphylococci in the hospital environment sensitivity to antibiotics].
    Ben Redjeb S; Ben Salah N; Bissardon O; Ennaifar M; Boujnah A
    Tunis Med; 1981; 59(4):307-9. PubMed ID: 7303174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hospital staphylococci. Sensitivity of 100 strains to antibiotics].
    Debeaumont A; Duriez J
    Nouv Presse Med; 1972 Apr; 1(15):1017. PubMed ID: 5018883
    [No Abstract]   [Full Text] [Related]  

  • 5. [Elimination of resistance to antibiotics and metal ions of hospital strains of Staphylococcus aureus].
    Młynarczyk A; Młynarczyk G; Osowiecki H
    Med Dosw Mikrobiol; 1980; 32(1):1-8. PubMed ID: 7412441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance spectrum of staphylococci at the Vienna general hospital (July to December 1991)].
    Aspöck C; Koller W; Rotter M; el Madani N; Seper E; Chizzali-Bonfadin C; Chizzali-Bonfadin C
    Wien Klin Wochenschr; 1994; 106(1):20-6. PubMed ID: 8135027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid resistance in three isolates of coagulase-negative staphylococci.
    Cieloszyk K; Amodio-Groton M; Saeed M; Coyle CM
    Ann Pharmacother; 2007 Mar; 41(3):526-7. PubMed ID: 17341527
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the resistance to antibiotics and bacteriophages of pathogenic staphylococci isolated from hospital environments and from collectivities of young children].
    Gherman DN; Zalman MW
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):629-35. PubMed ID: 4255814
    [No Abstract]   [Full Text] [Related]  

  • 9. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
    Hota B
    Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pleuro-pulmonary staphylococcal infection due to heterogenous resistant staphylococcus aureus. Role of the medical bacteriological laboratory].
    Pesnel G; Perrier M; Squinazi F; Geslin P; Douchain F; Fabre A; Reinert P; Lajouanine P
    Nouv Presse Med; 1975 Oct; 4(32):2321-4. PubMed ID: 1101214
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycopeptides in the treatment of staphylococcal infections.
    Daschner FD; Kropec A
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and antibiotic resistance of coagulase-negative staphylococci isolated from human nosocomial infections.
    Lenkei G; Belicza E; Sztroj T; Rédai I; Rozgonyi F
    J Chemother; 1989 Jul; 1(4 Suppl):277-9. PubMed ID: 16312400
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococci--the cause of hospital infections in an orthopedic department.
    Tselenis-Kotsowilis A; Saliarakis M; Stamos C; Papoutsakis L; Legakis NJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):18-9. PubMed ID: 3509386
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals.
    Petinaki E; Spiliopoulou I; Kontos F; Maniati M; Bersos Z; Stakias N; Malamou-Lada H; Koutsia-Carouzou Ch; Maniatis AN
    J Antimicrob Chemother; 2004 Jan; 53(1):105-8. PubMed ID: 14657085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
    Aepfelbacher M
    MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial hospitalism in the light of current knowledge on the origin and mechanism of antibiotic resistance].
    Lebek G
    Med Monatsschr; 1970 Apr; 24(4):142-5. PubMed ID: 5485956
    [No Abstract]   [Full Text] [Related]  

  • 18. Nosocomial infections: methicillin resistant Staphylococcus auerus in wound infection in Ibadan, Nigeria.
    Okesola AO; Oni AA; Bakare RA
    Afr J Med Med Sci; 1999; 28(1-2):55-7. PubMed ID: 12953988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical epidemiology of an outbreak of nosocomial infections by Staphylococcus aureus resistant to methicillin and aminoglucosides: efficacy of the measures of control].
    Parras F; Coello R
    Med Clin (Barc); 1993 Sep; 101(9):359. PubMed ID: 8412405
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.